tiprankstipranks
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
US Market
NWPHF
Newron Pharmaceuticals SpA
RESEARCH TOOLSreports
Want to see NWPHF full AI Analyst Report?

Newron Pharmaceuticals SpA (NWPHF) Financial Statements

12 Followers

Newron Pharmaceuticals SpA Financial Overview

Newron Pharmaceuticals SpA's market cap is currently $451.64M. The company's EPS TTM is $-0.76263528; its P/E ratio is -9.69; Newron Pharmaceuticals SpA is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 19.13M€ 51.39M€ 9.06M€ 6.09M€ 5.76M
Gross Profit€ 19.13M€ 51.39M€ 9.06M€ 6.09M€ 5.76M
Operating Income€ -4.70M€ 26.17M€ -11.63M€ -13.30M€ -12.36M
EBITDA€ -4.55M€ 25.94M€ -11.83M€ -13.32M€ -11.92M
Net Income€ -13.33M€ 15.84M€ -16.22M€ -17.49M€ -14.90M
Balance Sheet
Cash & Short-Term Investments€ 28.85M€ 9.83M€ 12.60M€ 22.77M€ 34.59M
Total Assets€ 40.02M€ 63.91M€ 25.87M€ 37.20M€ 50.49M
Total Debt€ 38.13M€ 50.47M€ 48.41M€ 45.66M€ 43.08M
Net Debt€ 25.96M€ 43.54M€ 42.08M€ 32.24M€ 18.06M
Total Liabilities€ 51.15M€ 62.45M€ 55.77M€ 51.23M€ 47.38M
Stockholders' Equity€ -11.13M€ 1.46M€ -29.91M€ -14.03M€ 3.11M
Cash Flow
Free Cash Flow€ 32.51M€ -17.63M€ -10.15M€ -11.11M€ -11.46M
Operating Cash Flow€ 32.56M€ -17.61M€ -10.14M€ -11.09M€ -11.45M
Investing Cash Flow€ -13.75M€ 3.16M€ 3.25M€ -317.00K€ 8.42M
Financing Cash Flow€ -13.52M€ 15.05M€ -192.00K€ -186.00K€ 14.83M
Currency in EUR

Newron Pharmaceuticals SpA Earnings and Revenue History

Income Statement >

Newron Pharmaceuticals SpA Debt to Assets

Balance Sheet >

Newron Pharmaceuticals SpA Cash Flow

Cash Flow >

Newron Pharmaceuticals SpA Forecast EPS vs Actual EPS

Earnings >